Industry Analysis
Entegris’ cross-licensing pact with JSR and Inpria transcends patent resolution—it reshapes the technical gatekeeping of EUV photoresists. By integrating metal-oxide and chemically amplified resists for sub-2nm nodes, the deal tightens process windows on ASML tools and forces Applied Materials and Lam to adapt deposition chemistries. Geopolitically, co-expansion in Taiwan, China and Colorado mitigates single-source risk, a critical compliance hedge amid U.S.-Japan export control coordination. Competitors like TOK and Shin-Etsu will likely accelerate in-house EUV validation, possibly triggering METI-led export curbs. The real test isn’t technology—it’s monetization. If AI capex peaks in 2027, Entegris’ premium valuation hinges on converting IP access into pricing power, not just volume.
This page displays AI-generated summaries and metadata for research purposes. Original content belongs to the respective publishers.